瑞必欧(上海)诊断技术有限公司 [Fujirebio China Co., Ltd. ]
Fujirebio China Co., Ltd.別名瑞必欧(上海)診断技術有限公司 [富士レビオ中国株式会社]別名Fujirebio China Co., Ltd.別名瑞必欧(上海)诊断技术有限公司別名瑞必欧(上海)诊断技术有限公司別名瑞必欧(上海)診断技術有限会社別名フジレビオ中国株式会社別名
銘柄コード
—
上場市場
—
国
従業員（単独）
—
関連会社
5
§01
基本情報
- 所在地
- 中国上海市长宁区红宝路188号古北SOHO A座3302室, 上海
- 社長
- 従業員数(単独)
- 従業員数(連結)
- 開始日
- 終了日
§02
サイト
§03
事業内容
CDMO (OEM)NeuroHPVAFP AntibodiesAMH ControlAmpFire® HPV High Risk GenotypingAmpFire® HPV Screening 16/18/HRAmyloid-β AntibodiesAntigensAuto-LIA™ 48Auto-LiPA™ 48BACE-1 AntibodiesBD-Tau AntibodiesBorrelia Line ImmunoblotC50 AntibodiesCA125 AntibodiesCA15-3 AntibodiesCA19-9 - AntibodiesCEA AntibodiesCanAg® AFP EIACanAg® CA125 EIACanAg® CA15-3 EIACanAg® CA19-9 EIACanAg® CA242™ EIACanAg® CEA EIACanAg® Free PSA EIACanAg® Glypican-3 EIACanAg® NSE EIACanAg® PSA EIACanAg® ProGRP EIACanAg® S100 EIACanAg® SCC EIACanChek™DOPA Decarboxylase AntibodiesDYNABLOT HEATDiaPlexQ™ ApoE Genotyping KitDiaPlexQ™ COVID-19 (N, ORF1a) Detection KitDiaPlexQ™ Flu A/B & SARS-CoV-2 Detection KitDiaPlexQ™ SARS-CoV-2 (N, ORF1a, RdRp) Fast Detection KitEBV LINE ImmunoblotFITC Anti-Rabies Monoclonal GlobulinFree PSA AntibodiesFuc-GM1 AntibodyHE4 EIAHIV-1, p24HPV-Risk assayIL-6 (Interleukin) LPGINNO-LIA® ANA UpdateINNO-LIA® HCV ScoreINNO-LIA® HIV I/II ScoreINNO-LIA® HTLV I/II ScoreINNO-LIA® Syphilis ScoreINNO-LiPA® CFTRiageINNO-LiPA® HBV GenotypingINNO-LiPA® HCV 2.0 ControlINNO-LiPA® HCV 2.0 GenotypingINNO-LiPA® HPV Genotyping Extra IIINNOTEST® HCV Ab IVINNOTEST® HIV Antigen mAbINNOTEST® PHOSPHO-TAU (181P)INNOTEST® PHOSPHO-TAU(181P)INNOTEST® hPLAPINNOTEST® hTAU AgINNOTEST® β-AMYLOID(1-40)INNOTEST® β-AMYLOID(1-42)Infectious disease antigens, HIV, HTLV, HCVInfectious disease antigens, SyphilisLIRAS® for LIPA® HBVLUMIPULSE® G1200LUMIPULSE® G600IILiRAS® for Infectious DiseasesLiRAS® for LIA® ANALiRAS® for LiPA HCVLiRAS® for LiPA® Cystic FibrosisLiRAS® for LiPA® HBVLiRAS® for LiPA® HLALiRAS® for LiPA® HPVLumipulse® ApoE4 ControlsLumipulse® B.R.A.H.M.S PCT ControlsLumipulse® G 25-OH Vitamin DLumipulse® G ADxPLORER® BD-TauLumipulse® G ADxPLORER® DDCLumipulse® G ADxPLORER® NPTX2Lumipulse® G ADxPLORER® NeurograninLumipulse® G ADxPLORER® VAMP2Lumipulse® G ADxPLORER® pTau231Lumipulse® G ADxPLORER® α-SynucleinLumipulse® G ADxPLORER® β-SynucleinLumipulse® G AFP-N (Alpha-Fetoprotein)Lumipulse® G AMH (anti-Müllerian hormone)Lumipulse® G AldosteroneLumipulse® G ApoE4Lumipulse® G B•R•A•H•M•S PCTLumipulse® G GFAPLumipulse® G HBcAb-NLumipulse® G HBcrAgLumipulse® G HMW AdiponectinLumipulse® G KL-6 (Krebs von den Lungen)Lumipulse® G MesothelinLumipulse® G NfL BloodLumipulse® G NfL Blood ControlsLumipulse® G NfL CSFLumipulse® G PIVKA-IILumipulse® G Pan-ApoELumipulse® G ReninLumipulse® G Total TauLumipulse® G pTau 181Lumipulse® G pTau 181 PlasmaLumipulse® G pTau 217 CSFLumipulse® G pTau 217 PlasmaLumipulse® G sTREM2Lumipulse® G whole PTHLumipulse® G β-Amyloid 1-40Lumipulse® G β-Amyloid 1-40 PlasmaLumipulse® G β-Amyloid 1-42Lumipulse® G β-Amyloid 1-42 PlasmaLumipulse® GFAP ControlsLumipulse® HBcrAg ControlsLumipulse® NfL Blood ControlsLumipulse® NfL CSF ControlsLumipulse® PIVKA-II and KL-6 ControlsLumipulse® PTH ControlsLumipulse® Renin ControlsLumipulse® SARS-CoV-2 Ag ControlsLumipulse® Total Tau ControlsLumipulse® pTau 181 ControlsLumipulse® pTau 181 Plasma ControlsLumipulse® pTau 217 CSF ControlsLumipulse® pTau 217 Plasma ControlLumipulse® pTau 217 Plasma ControlsLumipulse® sTREM2 ControlsLumipulse® β-Amyloid ControlsLumipulse® β-Amyloid Plasma ControlsLung Marker ControlMesothelin ControlMic qPCRNPTX2 AntibodiesNSE AntibodiesNeurofilament Light chain AntibodiesNeurogranin AntibodiesOther AntibodiesPHF-Tau AntibodiesPower-Gene 9600 PlusPreCursor-M AnoGYNPreCursor-M+RoboBlot™S100/S100BB/S100A1B AntibodiesSample Extraction SolutionSero Lumipulse IA control L1 and L2Seronorm™️ Immunoassay Lyo L-1Seronorm™️ Immunoassay Lyo L-2Soluble TREM-2 AntibodiesSynuclein AntibodiesTENDIGO™Tau AntibodiesThrombosis biomarkers, D-DimerTotal PSA AntibodiesTotal Tau AntibodiesTreponema pallidum LINE ImmunoblotTumor Marker ControlVAMP2 AntibodiesYersinia enterocolitica LINE ImmunoblotiAMP COVID-19 Detection KitiAMP COVID-19 SANO AssaypTau AntibodiesAlzheimer's disease testing solutionsHPV testingAntibody Identification and CharacterizationAntibody SupplyContract ManufacturingProduct DevelopmentClinical ServicesRegulatory ServicesPlasma Services Group provides sera and other samples for materials of control reagents and calibratCritical and high quality biological raw materials for IVD and life science industriesIVD testing technologiesunique biomarkersdiagnostic solutionsNeuro Center of ExcellenceNExT - the Neuro Expert ToolboxCollection, screening and supply of high quality and rare biological materials required for R&D and Provision of sera and other samples for control reagents and calibrators for a wide range of diseaseSample collection services globallyCDMO partnershipsDiagnostic Tools for Alzheimer’s DiseaseMedical EducationThe Fujirebio Neuro Center of Excellence
§04
関連会社
| 会社名 | Group | 親会社 | 子会社 | 得意先 | 仕入先 | 業務提携 | 銀行等 | 株主等 |
|---|---|---|---|---|---|---|---|---|
| 富士レビオ株式会社 | ||||||||
|
|
||||||||
|
|
||||||||
|
|
||||||||
| Plasma Services Group |
リンク無しの社名は OpenBizGraph 未登録企業
§05
関連図
資本関係
得意先
仕入先
業務提携
銀行・株主
ドラッグで移動 · クリックで詳細へ
§06
沿革
Fujirebio (formerly Fujizoki Pharmaceutical, Co., Inc.) is founded in Tokyo, Japan.
Launch of HA Ag (TPHA), the world’s first hemagglutination test for syphilis.
Launch of the syphilis SERODIA®-TP•PA test kit, destined to become a gold standard.
Established Fujirebio Taiwan Inc.
Established Fujirebio America, Inc. (merged to Fujirebio Diagnostics, Inc.) in USA.
Established Fujirebio Holdings, Inc., as parent company of Fujirebio Inc., Fujirebio Diagnostics, Inc., Fujirebio Europe N.V. and other Fujirebio group companies.
Launched Lumipulse G β-Amyloid 1-42
Established Fujirebio Diagnostics Japan, Inc., focusing on OEM business in Japan.
Established Fujirebio China Co., Ltd.
Launched Lumipulse G β-Amyloid 1-42.
Centocor Diagnostics in 1998
Centocor Diagnostics in 1998.
CanAg Diagnostics in 2006
CanAg Diagnostics in 2006.
Advanced Life Science Institute, Inc. and American Biological Technologies, Inc. in 2008.
Innogenetics in 2010
Innogenetics in 2010.
ADx NeuroSciences and Fluxus, Inc. in 2022.
§07
ニュース
ニュースはありません。
§09
出典・更新
DOMAIN単独ドメイン：あり
UPDATED2026-10-29 21:22 · Model: gpt-oss-20b(16)